Redpoint Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Redpoint Investment Management's AMGN Position: Q3 2022 in Review
Redpoint Investment Management reduced its Amgen (AMGN) stake by 12% in Q3 2022, selling an estimated $416K and leaving 12,051 shares worth $2.72M. The position accounts for 0.4% of the portfolio, ranked #50.
Redpoint Investment Management first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $15.5M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Redpoint Investment Management held 12,051 shares of Amgen worth $2.72M as of Q3 2022.
- Redpoint Investment Management sold 1,718 Amgen shares in Q3 2022, an estimated $416K.
- Amgen made up 0.4% of Redpoint Investment Management's portfolio in Q3 2022, its #50 holding.
- Redpoint Investment Management first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Amgen position peaked at $15.5M in Q3 2018.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.